2012

/Tag:2012

Oramed Pharmaceuticals Chosen to Present at the XVI International Symposium on Atherosclerosis (ISA2012), (March 25-29, 2012; Sydney, Australia)

Warning: file_get_contents(http://xml.corporate-ir.net/irxmlclient.asp?compid=180902&reqtype=releasetxt&reqid=1674391): failed to open stream: HTTP request failed! HTTP/1.1 400 BAD_REQUEST in /home/oramedco/domains/oramed.com/public_html/wp-content/themes/Shiksite-Child-Theme/functions.php on line 237 Notice: Trying to get property of non-object in /home/oramedco/domains/oramed.com/public_html/wp-content/themes/Shiksite-Child-Theme/functions.php on line 239 Notice: Trying to get property of non-object in /home/oramedco/domains/oramed.com/public_html/wp-content/themes/Shiksite-Child-Theme/functions.php on line 239

2018-05-30T17:04:47+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Announces Educational Lecture at the National University Hospital in Singapore

JERUSALEM, February 7, 2012 /PRNewswire via COMTEX/ --Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (https://www.oramed.com), a developer of oral delivery systems, announced today that Dr Miriam Kidron, Oramed's Chief Medical and Technology Officer, will be delivering a lecture at the National University Hospital (NUH) in Singapore. The [...]

2018-05-30T17:04:47+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company’s Core Technology in Oral Delivery of Proteins

JERUSALEM, January 24, 2012 /PRNewswire/ -- Marking a major milestone for the Company, Oramed Pharmaceuticals Inc. (OTCBB: ORMP) (https://www.oramed.com), a developer of oral drug delivery systems, announced today that it has received approval for a key patent by the Australian Patent Office. The patent covers [...]

2018-05-30T17:04:48+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes

Oral treatment can increase patient compliance in the estimated $15 billion US market JERUSALEM, January 10, 2012 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (https://www.oramed.com), a developer of oral drug delivery systems, announced today that it has filed a provisional patent application with the United States [...]

2018-05-30T17:04:48+00:00 Categories: Press Releases|Tags: |